1. Home
  2. PODD vs EXPD Comparison

PODD vs EXPD Comparison

Compare PODD & EXPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • EXPD
  • Stock Information
  • Founded
  • PODD 2000
  • EXPD 1979
  • Country
  • PODD United States
  • EXPD United States
  • Employees
  • PODD N/A
  • EXPD N/A
  • Industry
  • PODD Medical/Dental Instruments
  • EXPD Oil Refining/Marketing
  • Sector
  • PODD Health Care
  • EXPD Consumer Discretionary
  • Exchange
  • PODD Nasdaq
  • EXPD Nasdaq
  • Market Cap
  • PODD 19.0B
  • EXPD 16.0B
  • IPO Year
  • PODD 2007
  • EXPD N/A
  • Fundamental
  • Price
  • PODD $258.75
  • EXPD $119.71
  • Analyst Decision
  • PODD Buy
  • EXPD Hold
  • Analyst Count
  • PODD 17
  • EXPD 11
  • Target Price
  • PODD $294.65
  • EXPD $116.11
  • AVG Volume (30 Days)
  • PODD 880.6K
  • EXPD 1.7M
  • Earning Date
  • PODD 05-08-2025
  • EXPD 05-06-2025
  • Dividend Yield
  • PODD N/A
  • EXPD 1.22%
  • EPS Growth
  • PODD 96.55
  • EXPD 14.17
  • EPS
  • PODD 5.78
  • EXPD 5.72
  • Revenue
  • PODD $2,071,600,000.00
  • EXPD $10,600,515,000.00
  • Revenue This Year
  • PODD $20.58
  • EXPD $2.03
  • Revenue Next Year
  • PODD $17.41
  • EXPD $1.73
  • P/E Ratio
  • PODD $44.73
  • EXPD $20.98
  • Revenue Growth
  • PODD 22.07
  • EXPD 13.98
  • 52 Week Low
  • PODD $160.19
  • EXPD $108.36
  • 52 Week High
  • PODD $289.46
  • EXPD $131.59
  • Technical
  • Relative Strength Index (RSI)
  • PODD 44.69
  • EXPD 56.80
  • Support Level
  • PODD $258.25
  • EXPD $118.62
  • Resistance Level
  • PODD $276.13
  • EXPD $120.65
  • Average True Range (ATR)
  • PODD 8.60
  • EXPD 2.26
  • MACD
  • PODD 0.94
  • EXPD 0.11
  • Stochastic Oscillator
  • PODD 55.53
  • EXPD 66.32

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it world-wide.

About EXPD Expeditors International of Washington Inc.

Expeditors International of Washington is a non-asset-based third-party logistics provider, focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. Expeditors derives around 34% of consolidated net revenue from airfreight, 30% from ocean freight, and 36% from customs brokerage and other services.

Share on Social Networks: